Funding Rounds
AMLo Biosciences

AMLo Biosciences Unknown (2022, $3M)

AMLo Biosciences

Platform identifying high-risk melanoma through loss of specific skin proteins.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $3.20M

Raised Date: 2022-01-01